Raxibacumab Injection
Product Images NDC 71655-103

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Raxibacumab (NDC 71655-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Manufacturing Operations Baltimore Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Raxibacumab 35 mL Carton Label (Raxibacumab Spl Graphic 01)

Box packaging label for Raxibacumab Injection, 1700 mg/34 mL (50 mg/mL) for intravenous infusion. The label indicates the product must be diluted prior to use and is a single-use vial with unused portions to be discarded. It is manufactured by Emergent Manufacturing Operations Baltimore LLC. Storage instructions include refrigeration at 2° to 8°C and protection from light. No preservative or U.S. standard of potency is specified.*

FDA Label Image

Raxibacumab 35 mL Vial Label (Raxibacumab Spl Graphic 02)

Label for Raxibacumab Injection, 1700 mg/34 mL (50 mg/mL) strength, intended for intravenous infusion. The product is a single-use vial requiring dilution prior to use. It is manufactured by Emergent Manufacturing Operations Baltimore LLC. Storage instructions include refrigeration at 2° to 8°C and protection from light. The label includes the NDC number 71655-103-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.